Docquity, a healthcare professional (HCP) network in Southeast Asia, has announced a new partnership with RSUD Umar Wirahadikusumah Sumedang in West Java, Indonesia. This collaboration integrates Dx, Docquity’s AI-powered medical resource platform, into the hospital’s medical reference system, offering doctors quick access to credible research and enhancing clinical decision-making.

Docquity’s partnership with RSUD Umar Wirahadikusumah Sumedang is part of its broader mission to improve healthcare decision-making through technology. According to Amit Vithal, Co-Founder and Chief of Growth at Docquity, this collaboration enables HCPs to retrieve evidence-based medical insights efficiently, reducing the time spent searching for reliable references.

“The integration of Dx into the hospital’s system ensures that doctors have seamless access to up-to-date clinical knowledge, improving efficiency and supporting better patient outcomes,” said Vithal in an email interview with e27.

The partnership also serves as a real-world testing ground for refining Dx’s usability in a hospital environment and aligning it with Indonesia’s healthcare landscape.

Dx is designed to function as an AI-powered medical resource assistant, offering doctors in Indonesia instant access to clinical knowledge from trusted sources such as PubMed and international guidelines. One of its key advantages is its ability to tailor insights to local medical practices, ensuring that the information provided is both globally authoritative and regionally relevant.

“Dx is being developed to support doctors with region-specific guidelines and a high degree of localisation,” Vithal explained. “Our aim is to make high-quality medical knowledge more accessible, particularly for general practitioners and specialists who require quick decision support.”

Also Read: Bridging healthcare and cybersecurity: How women are challenging stereotypes in tech

Addressing Indonesia’s healthcare challenges

Indonesia’s healthcare system faces significant challenges, particularly in terms of workforce shortages. With a doctor-to-population ratio of 0.6 per 1,000—well below the World Health Organization’s recommended 1:1,000 and lower than neighbouring countries such as Thailand (0.95) and Malaysia (2.2)—doctors are often under pressure, especially in rural areas where access to up-to-date medical references is limited.

Dx is designed to help bridge this gap by providing instant, evidence-based clinical knowledge, allowing doctors to make faster and more informed decisions.

“As Indonesia works towards improving its doctor-to-population ratio, Dx can enhance efficiency, improve access to reliable medical information, and support better patient care nationwide,” Vithal said.

AI plays a crucial role in making medical information more accessible and accurate. Dx processes vast amounts of medical data and presents only the most relevant insights in a concise format. Docquity ensures reliability by sourcing information from credible databases such as PubMed and official medical guidelines.

“Adapting Dx for Indonesia involves improving language support, contextualising content for local clinical practices, and ensuring alignment with national medical guidelines,” Vithal noted. “Additionally, we prioritise transparency, allowing doctors to trace the sources of information Dx provides.”

Since its implementation at RSUD Umar Wirahadikusumah Sumedang, Dx has received a positive response from healthcare professionals. Doctors have highlighted how much easier it is to use Dx compared to previous tools, with its intuitive interface and seamless integration into hospital workflows being key advantages.

“The feedback from doctors has been overwhelmingly positive, as they find Dx significantly more efficient in accessing crucial medical references,” Vithal stated.

Also Read: Empowering women in healthtech: The role of technology in driving inclusive workplaces

Future expansion plans across Indonesia and Southeast Asia

Indonesia remains a priority market for Docquity, and the company plans to expand Dx’s adoption by collaborating with hospitals, medical associations, and government stakeholders. “Our strategy includes integrating Dx into hospital workflows, working on medical education initiatives, and ensuring the AI aligns with national healthcare priorities,” Vithal explained.

Beyond hospitals, Docquity is also looking at ways to make Dx more accessible to private practitioners, broadening its impact across Indonesia’s healthcare ecosystem. The company envisions AI-powered solutions like Dx playing an increasing role in improving medical knowledge accessibility throughout Southeast Asia.

As AI continues to evolve, its role in medical education and clinical decision support is expected to grow. Docquity sees AI as an essential tool for enhancing, not replacing, human judgment.

“With Dx, our vision is to empower doctors with AI-driven insights that complement their expertise, making continuous learning and evidence-based practice more seamless,” Vithal said. “AI can help doctors stay updated with medical advancements while allowing them to focus on patient care.”

—

Image Credit: Docquity

The post Docquity expands AI-powered medical reference platform in Indonesia through hospital partnership appeared first on e27.